Perrigo Company plc Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray
[PR Newswire] – DUBLIN, May 12, 2014 /PRNewswire/ — Perrigo Company plc (NYSE: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for azelastine hydroc more
View todays social media effects on PRGO
View the latest stocks trending across Twitter. Click to view dashboard